Andi Gardner
Transforming Strategic Alliances into Engines of Growth, Trust & Operational Excellence
- Role
- Senior Director Alliance Management at Biogen
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Andi Gardner
Strategic alliance executive with 15+ years of experience leading complex biopharma partnerships across the research, development, and commercialization lifecycle. Proven track record of navigating high-stakes governance, aligning cross-functional teams, and translating strategic vision into measurable, value-driven outcomes. Recognized for bringing clarity to ambiguity, accelerating performance, and fostering high-impact collaborations rooted in trust, transparency, and shared success.Skilled in alliance management, operational governance, strategic planning, contract renegotiation, and executive communication. Adept at managing geographically and culturally diverse partnerships across Asia, Europe, the U.S, Latin America, and the Middle East. Known as a business-savvy, multilingual influencer who blends structured execution with stakeholder diplomacy—operationalizing complex contracts while balancing cross-functional priorities and enabling global expansion.Career Highlights- Delivered $2.3B Exit Value as part of the deal team that led Biogen’s divestment of its biosimilar joint venture with Samsung Biologics; operationalized surviving license and commercialization agreements post-sale- Co-led $1.1B Integration for Eli Lilly’s acquisition of Dermira, onboarding the lebrikizumab team and establishing alliance management capabilities from the ground up- Built & Scaled Global Alliances across the full product lifecycle (preclinical to commercial) in CNS and hematology, managing complex, multiproduct partnerships worldwide- Drove Double-Digit Growth at Color Genomics by renegotiating 30+ strategic alliance contracts across Asia, Europe, and Latin America—boosting revenue and operational efficiency- Expanded Amgen\'s Global Portfolio, managing high-value alliances across oncology, hematology, and nephrology. Grew revenues from $7.5M to $12.6M in two years while overseeing key brands like Vectibix®, Kyprolis®, and Sensipar®- Repatriated $18M Filgrastim Franchise from Roche in 10 markets without operational disruption—ensuring continuity and local execution- P&L Owner & Builder for Lonza’s Latin America life sciences division—launched regional operations, built a 10-person team, and scaled revenue from $400K to $6M over five years.
Experience
Senior Director Alliance Management
Jun 2024 — Present · Boston, MA, US
Education
Universidade São Francisco
Doctor of Pharmacy (Pharm.D.), Pharmaceutical Sciences
Pepperdine Graziadio Business School
Master of Business Administration (M.B.A.), Business Administration and Management, General
Stanford University
Communication, General
2020 — 2020
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.